SUPERNUS Regulatory Monday, November 2, 2026 +0.10 Neutral

Supernus Pharmaceuticals files amended certificate of incorporation

The company filed a restated certificate of incorporation with the SEC, which includes provisions to limit the liability of directors and officers and to indemnify them against certain legal expenses.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed